Powered by: Motilal Oswal
2026-02-10 01:00:44 pm | Source: Accord Fintech
Marico moves up as its arm inks pact to acquire 75% equity stake in Skinetiq
Marico moves up as its arm inks pact to acquire 75% equity stake in Skinetiq

Marico is currently trading at Rs. 757.00, up by 2.05 points or 0.27% from its previous closing of Rs. 754.95 on the BSE.

The scrip opened at Rs. 761.35 and has touched a high and low of Rs. 761.35 and Rs. 749.65 respectively. So far 10799 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 780.00 on 06-Jan-2026 and a 52 week low of Rs. 577.90 on 04-Mar-2025.

Last one week high and low of the scrip stood at Rs. 764.75 and Rs. 724.65 respectively. The current market cap of the company is Rs. 98266.80 crore.

The promoters holding in the company stood at 58.93%, while Institutions and Non-Institutions held 36.35% and 4.72% respectively.

Marico’s wholly owned subsidiary -- Marico South-East Asia Corporation (MSEA) has entered into definitive agreements to acquire 75% equity stake in Skinetiq Joint Stock Company (Skinetiq). The said transaction is aligning with Marico’s long term strategy of building a strong premium beauty play in Vietnam, while enabling participation in the country’s growing D2C beauty market and also realizing various operational synergies.

The transaction is expected to be completed within 90 days from the date of signing definitive agreements, subject to receipt of requisite regulatory approvals and customary closing conditions.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here